biomanufacturing jim dekloe

32
Biotechnology 101 Business and Regulatory Practices 1 Biomanufacturing Jim DeKloe

Upload: toan

Post on 18-Feb-2016

34 views

Category:

Documents


1 download

DESCRIPTION

Biomanufacturing Jim DeKloe. Biotechnology is the intersection of Science Business Government. Traditional Pharmaceutical “Big Pharma” Drugs Small molecules Produced by Chemistry Example: Aspirin. Biotechnology companies “Biotech” Proteins Large Molecules - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

1

Biomanufacturing

Jim DeKloe

Page 2: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

2

Biotechnology is the intersection of

Science

Business

Government

Page 3: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

3

Page 4: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

4

Drugs versus “biotech”

Traditional Pharmaceutical

“Big Pharma”

Drugs

Small molecules

Produced by Chemistry

Example: Aspirin

Biotechnology companies

“Biotech”

Proteins

Large Molecules

Produced by Living Organisms

Example: EPO

Page 5: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

5

History

Drugs

Small molecules

Produced by Chemistry

Simple Pure Molecules

Easy to Test Quality

Example: Aspirin

Biologics

Complicated Mixture of Large Molecules

Difficult to Test Purity

Emphasis on Consistent Process

Examples:

Vaccines, Plasma and Serum

Page 6: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

Technician Training

Biotech clusters thrive when all elements of the industry are represented

Until recently, the emphasis on R & D meant that formal training targeting technicians was rare

Community Colleges have moved into this niche

Technician training will be even more important as more companies move from R & D into biomanufacturing

Page 7: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

A Model Academic - Industry Collaboration

Building biomanufacturing curriculum

Tailoring curriculum to develop specific required skills

Incorporating regulatory requirements into curriculum

Page 8: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

Genentech suppliedSabbatical Experience

Expertise

Donated Equipment

Presence on Advisory Committee

Guest Speakers

Page 9: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

Traditional versus IndustrialTraditional Industrial

Education Training

Lab Atmosphere Pilot Plant Atmosphere

Set Times Shifts

Lab Protocols SOP

Lab Notebook Batch Records

Individual Team

Page 10: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

Question Authority!Change Academic Paradigm

Borrow vocational tech and business ideas

Teach skills as well as educate

Emulate the industrial experience

Share the ideas that work

Page 11: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

11

Back to Basics - Cells

Page 12: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

12

Eukaryotic Cells can be Engineered Also

Page 13: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

13

Protein!

The Protein is the Product!

Page 14: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

14

Protein Structure

Proteins can be modified after they are synthesized

The addition of sugars – glycosylation – may be important – it affects solubility and pharmacokinetics (blood half live)

Glycosylation patterns may vary

Repeat because it is so important: If a protein loses this shape, it loses its function

Page 15: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

15

Protein!

The protein must not be unfolded (denatured) or it loses its function. Proteins can be denatured by:

•pH extremes

•temperature extremes

•organic chemicals

•agitation

Page 16: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

16

Protein!

DNA is the Flash

Protein is the Cash

Page 17: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

17

Protein!

DNA is the Show

Protein is the Dough

Page 18: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

18

Protein!

DNA is the Bling

Protein is the Thing

Page 19: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

19

Bacterial Cells – Prokaryotic Cells

Page 20: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

20

Cells are grown in a large scale

Page 21: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

21

Upstream

Cells Divide and are transferred to larger and larger volumes

Cells are induced to produce protein

Many in-process samples are taken; some are sent to QC for a variety of tests. For mammalian cells, they will check for contamination by viruses and mycoplasma

Page 22: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

22

Recovery - Downstream

Cells are separated from the medium surrounding them by filtration or centrifugation.

Typically:

In E. coli culture (slang is fermentation), the cells are retained and the medium is discarded

In cell culture (CHO cells), the cells have been engineered to secrete the protein, so the cells are discarded and the protein-containing medium is retained

Page 23: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

23

Protein Purification

The protein of interest must be separated from the other proteins in the cells or medium until it is 99.99% pure.

This is accomplished by ultrafiltration and chromatography

Page 24: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

24

Ultrafiltration

In ultrafiltration the protein containing solution is passed through a filter with pores of a defined size. This can separate proteins of different sizes from one another, or can separate protein from medium components.

Page 25: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

25

Chromatography

Chromatography methods use resins of different types to exploit the characteristics of the protein to interest to separate it from other contaminating protein

Page 26: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

26

Types of Chromatography

Type of Chromatography Protein Property

•Gel Filtration (Size Exclusion) - Size

•Ion Exchange (Cation or Anion) – Charge

•Hydrophobic Interaction Chrom. – Hydrophobicity

•Affinity Chromatography - Function or Special Characteristic

Page 27: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

27

Formulation

Once the protein has been purified, the bulk purified protein will be placed in the formulation buffer and sterile filtered. During formulation, adjuncts are added to:

•Stablize pH

•Adjust osmolarity

•Prevent aggregation

•Cryoprotect (for lyophilized products)

Page 28: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

28

Fill

Fill is completed in a special facility that has highly filtered air, gowned personnel with special training, This process is highly automated.

A measured amount of the formulated protein is aliquoted into sterile ampules

Page 29: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

29

Finish

The protein may be lyophilized (freeze dried). This makes it more stable, but physicians may find this form of the drug less convenient to use.

Closures are added

Labels are applied.

Page 30: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

30

Quality Assurance

The law requires a QA/QC department that is separate from manufacturing

They will test:

Raw Materials

In-Process Samples

Utilities

Environmental Monitoring

The final protein product

Page 31: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

31

Regulation

In the United States, the Food and Drug Administration regulates pharmaceutical production

•Part of the executive branch

•Regulates $ 1 trillion of commerce a year

•Center for Drug Evaluation and Research

•Center for Biologics Evaluation and Research

Page 32: Biomanufacturing Jim DeKloe

Biotechnology 101Business and Regulatory Practices

32

What Are GMPs?

Subpart DescriptionA General Provisions

B Organization and Personnel

C Buildings and Facilities

D Equipment

E Control of Components and Drug Product Containers and Closures

F Production and Process Controls

G Packaging and Labeling Controls

H Holding and Distribution

I Laboratory Controls

J Records and Reports

K Returned and Salvaged Drug Products